AYTU insider trading
NasdaqCM HealthcareAYTU BIOPHARMA, INC: insider trade history from SEC Form 4 filings.
About AYTU BIOPHARMA, INC
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
Company website: aytubio.com
AYTU insider activity at a glance
FilingIQ tracks 160 insider transactions for AYTU in filings since Dec 3, 2015. The most recent transaction is dated Jul 28, 2026.
Across the full history, 29 open-market purchases
and 8 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest AYTU Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for AYTU?
- FilingIQ tracks 160 Form 4 insider transactions for AYTU (AYTU BIOPHARMA, INC), covering filings from Dec 3, 2015 onwards. 8 of those are dated within the last 90 days.
- Are AYTU insiders net buyers or net sellers?
- Across the full Form 4 history for AYTU, 29 transactions (18%) were open-market purchases and 8 (5%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does AYTU insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is AYTU in?
- AYTU BIOPHARMA, INC (AYTU) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $23.61M.
Methodology & sources
Every AYTU insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.